Background The clinical assessment of axillary lymph nodes status and tumor size is important for the management of patients with breast cancer. The first goal of this study was to determine the accuracy of axillary lymph node status in relation to the presence of metastases as revealed by histopathological examination. The second goal was to compare the tumor size as assessed by physical examination, with the size obtained by histopathological examination. Methods This study was based on a consecutive series of 2,537 patients diagnosed with breast cancer in Malmö, Sweden, between 1987 and 2002. These patients had available information in the South Swedish Breast Cancer Group registry, corresponding to 97 %. The axillary lymph nodes status was compared with the results of the histopathological examination for the presence of metastases. Tumor size by physical examination was compared with the tumor size after histopathological examination. Results There were 674 women with axillary lymph nodes metastases according to histological examination; only 206 of these cases had palpable lymph nodes at clinical examination. The sensitivity was 30 % and the specificity 93 %. There were 812 tumors measured to be larger than 20 mm according to histopathological examination, but only 665 of these tumors were considered larger than 20 mm by clinical examination. This corresponded to a sensitivity of 81 % and a specificity of 80 %.
Introduction
Clinical assessment of axillary lymph nodes status is an important factor in planning of the surgical strategy in patients with breast cancer [1] [2] [3] [4] . The likelihood of axillary lymph node metastases as determined by clinical examination before histological examination is difficult to predict [3, [5] [6] [7] . Clinically palpable axillary lymph nodes are widely considered as a contraindication to the sentinel lymph node procedure [2, 6] ; as a consequence, a number of patients without regional disease are undergoing axillary dissection with subsequent potential complications [8] .
Preoperative assessment of tumor size in breast cancer also is an important key factor in deciding the appropriate treatment according to current guidelines for the management of breast cancer [9] . Tumor size may be estimated using different modalities before surgery, but clinical assessment by palpation remains the first and easiest way to estimate tumor size. There may be a considerable difference between the estimated tumor sizes preoperatively and after histological examination [1, 10, 11] .
This study was based on a consecutive series of 2,537 patients diagnosed with breast cancer in Malmö, Sweden, between 1987 and 2002.
The goal of the present study was to determine the accuracy of clinically assessed axillary lymph node status in relation to the presence of metastases as revealed by histopathological examination postoperatively. An additional goal was to compare the preoperative tumor size as assessed by physical examination, with the size obtained by histopathological examination.
Materials and methods

Patient registry
The South Swedish Breast Cancer Group (SSBCG), which was established in 1977, has issued guidelines for treatment of patients with breast cancer [12] . SSBCG set up a clinical registry in 1981, which continued until 2003. In Malmö since 1977, each patient with breast cancer is reviewed and discussed at a weekly breast cancer conference at which there are representatives from the Departments of oncology, radiology, surgery, plastic surgery, and pathology.
Decision about the management, i.e., extent of surgery and the use of adjuvant therapy, primarily depends on tumor size, lymph node status, hormone receptor status, age, and menopausal status. All of this information was entered into the register run by the SSBCG.
Data about the axillary lymph node status by physical examination were collected together with the results obtained by histopathological examination of these lymph nodes. Information also was collected on tumor size according to the physical examination before the surgery and after the histopathological examination, TNM, type of surgery, and adjuvant treatment.
All of the information was already available at a computerized database at The South Sweden Regional Tumour Registry.
Study population
All cases with breast cancer diagnosed in Malmö, or registered as residents in Malmö, between 1961 and 2004 were retrieved from The Regional Tumour Registry during the autumn of 2005.
After excluding cases with unknown civil registration number (n = 6), multiple cases in the same individual (n = 1,921), benign lesions (n = 26), cases diagnosed before the establishment of the clinical registry at the SSBCG in 1981 (n = 3,326), and following end of data collection into the SSBCG registry, December 31, 2003 (n = 245), 4,557 cases remained. Of them, 202 were not registered as residents in Malmö, 481 had been treated outside Malmö, and 28 were found at autopsy. An additional 41 cases had a mismatch between date of diagnosis in The Regional Tumour Registry and the SSBCG registry of more than 180 days. This left 3,805 cases. Routines for collection of information in to the SSBCG registry had changed slightly over time, with many missing cases in the beginning of the period and during the last year the SSBCG registry was run. The final cohort consisted of cases diagnosed between January 1, 1987 and December 31, 2002, in all 2,629 individuals. Of these 2,629 women, 2,537 individuals had available information in the SSBCG registry, corresponding to 97 %.
Statistical methods
Axillary lymph node status by physical examination was regarded as positive in case of palpable lymph nodes and as negative in case of nonpalpable lymph nodes. The axillary status was compared with the results of the histological examination for the presence of metastases. Axillary lymph nodes with metastases were regarded as positive and those without metastases as negative.
The patients were divided into two groups according to tumor size: those with tumors \20 mm, and those with tumors [20 mm. This choice was made according to the TNM classification [13, 14] . Tumor size by physical examination preoperatively was compared with the size of the tumor after histological examination.
A ''positive test'' for axillary lymph node status was palpable lymph nodes and for tumor size it was a tumor perceived as larger than 20 mm. Sensitivity, specificity, positive predicative value (PPV), negative predicative value (NPV), positive likelihood ratio (?LR), negative likelihood ratio (-LR), and 95 % confidence intervals (CI) were calculated. Confidence intervals for the estimated parameters were computed by a general method (based on constant v 2 boundaries) [15] . Comparisons were made in two different periods: 1987-1994 and 1995-2002 . Patients were further divided into three age groups. One group assumed to be mainly premenopausal age \50 years, a second group assumed to be mostly postmenopausal aged 50-70 years, i.e., women invited to the mammography screening program, and a third group of postmenopausal women aged [70 years.
Results
There were 674 women with axillary lymph nodes metastases according to histological examination; only 206 of these cases had palpable lymph nodes at clinical examination. The sensitivity was 30 %, the specificity 93 %, the PPV 76 %, and the NPV 67 % (Table 1) . Sensitivity was low and specificity was high in all age groups. The ?LR was 5.1 and -LR was 0.73. No large differences were noticed in relation to different time periods (Table 1) .
According to histopathological examination, there were 812 tumors measured to be larger than 20 mm, but only 665 of these tumors were considered larger than 20 mm by clinical examination. This corresponded to a sensitivity of 81 %, a specificity of 80 %, a PPV of 72.0 %, and a NPV of 87 %. Sensitivity related to the preoperative diagnosis of tumors larger than 20 mm was considerably higher for women older than age 70 years, whereas this group had a lower specificity concerning the detection of tumors larger than 20 mm. The ?LR was 4.2 and the -LR was 0.22. All results were similar in relation to different time periods (Table 2) .
Discussion
Among women with palpable lymph nodes, 24 % had no lymph node metastases, and in women with no palpable lymph nodes 32 % had lymph node metastases according to the histopathological examination. This suggests large difficulties in the clinical estimation of the axillary lymph nodes status.
Patients with clinically suspicious axillary nodes comprise a variety of findings. Normal lymph nodes vary widely in size, consistency, and fat content [3, 16] . Lymphadenopathy is an element of many nonmalignant diseases, and reactive adenopathy may not be distinguishable from metastasis [16] .
Clinically positive axillary lymph nodes are usually considered as a sign of regional metastases, whereas their absence is regarded as a good prognostic factor [17] . However, several previous studies have shown that clinical examination of axillary lymph nodes and estimation of suspicious metastases by palpation is an inaccurate way of assessment even when the examination is performed by an experienced surgeon [2, 18] . Lanng et al. [6] showed in a study involving 301 patients that even if the examination was performed by a specialist breast surgeon, the examination had little value. When the surgeons considered the axilla to be normal, they were wrong in 44 % of cases. Other studies have reported similar results, e.g., Voogd et al. [18] who showed in a population-based study involving 5,123 patients that 34 % of patients who were known to have nonpalpable lymph nodes before surgery had positive lymph nodes at pathological examination after axillary dissection.
Tumor size by palpation had a high specificity concerning the detection of tumors larger than 20 mm in premenopausal women, whereas it had a low specificity in postmenopausal women where overestimation of tumor size at palpation was most common.
Tumor size estimated by physical examination was used in this analysis, although the palpated tumor size is usually used in decision making along with radiological size. This is particularly the case when dealing with tumors larger than 40 mm where neoadjuvant therapy might be the primary choice of treatment [12] . In addition, the estimated tumor size is an important factor peroperatively in cases of partial mastectomy and breast conservative surgery to achieve sufficient macroscopic marginal.
There are different ways to estimate tumor size; physical examination, mammography, and ultrasonography are common methods, and many studies have indicated that measurement by ultrasonography is the most accurate way [9, [19] [20] [21] , e.g., Hieken et al. [20] who showed in a study that included 180 patients with invasive breast cancer that ultrasonography is more accurate than mammography in assessing breast cancer size. Moreover, Shoma et al. [19] showed in a study involving 162 patients that it was common to overestimate the tumor size during clinical examination.
Overestimation of the tumor size may be due to several reasons. Local bleeding and increased inflammatory reaction/edema after biopsy could result in an overestimation. In addition, the physical palpation includes not only the tumor but also the surrounding tissue and the skin, which in turn might increase the estimated tumor size [3, 10] .
Another explanation could be that breast specimens undergo shrinkage after histological fixation; Docquier et al. [21] and Yeap et al. [22] suggested that breast specimens undergo shrinkage after histological fixation, losing more than a third of their original closest free margin, whereas the tumor itself does not shrink substantially.
The strengths of the present study include the size of the sample: more than 2,500 patients with breast cancer. The patient cohort was a population-based consecutive series, and there was no selection, in terms of tumor stage or other reasons, to or from Malmö University Hospital. Validity of the diagnosis was probably very high as cases were identified from two sources: The Regional Cancer Registry and the clinical registry run by the SSBCG. The histopathological assessment was performed at one department of a limited number of pathologists, several of them working in the department for decades. Similarly, all preoperative examinations were performed in the same surgical department.
Our study shows that estimation of suspicious regional metastases by clinical examination is very difficult, and finding palpable lymph nodes during clinical examination in patients with breast cancer does not necessarily mean regional metastases of breast cancer. This is of great importance, because palpable lymph nodes are widely considered a contraindication for performing the sentinel node procedure [2, 6] , which may save these patients from an unnecessary axillary lymph node dissection [23] . On the other hand, the absence of palpable lymph nodes in the axilla does not exclude metastases. There are different ways to assess the axillary lymph node status before surgery, i.e., physical examination, radiological examination (ultrasonography, mammography, CT, PET-CT, and MRI), and needle biopsies. The present study indicates the need for such additional examinations to improve accuracy of the preoperative assessment of axillary lymph node status.
The result of our study also indicate that whenever the preoperative tumor size at physical examination is used as decision-making value in choosing the appropriate management of patients with breast cancer, there is a clear risk of over-and underestimation of tumor size, and additional measurement by help of other modalities must be taken in consideration.
We conclude that the possibility of axillary metastases estimated by clinical examination is subject to a large proportion of false-positive and false-negative results. Similarly, tumor size estimated by clinical examination is subject to a considerable misclassification with both under-and overestimation compared with histopathological results. All measurements with a 95 % confidence interval (CI)
